The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed its fortunes.
Več na: https://www.nytimes.com/2025/08/07/business/ozempic-wegovy-novo-nordisk-decline.html
nazaj
